ArticleFrontiers in immunology2025
Case Report: Abscopal effect of radiotherapy in a patient with metastatic duodenal adenocarcinoma and resistance to chemoimmunotherapy.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Duodenal adenocarcinoma is a rare gastrointestinal malignancy, with limited clinical treatment data and a poor prognosis, especially when metastatic. Standard therapies such as chemotherapy and immunotherapy often exhibit limited efficacy, particularly in advanced stages of the disease. The abscopal effect, where local radiotherapy leads to regression of distant metastatic lesions, has been documented in various cancers but is not well explored in duodenal adenocarcinoma. This case report evaluates the potential for radiotherapy to induce an abscopal effect in a patient with metastatic duodenal adenocarcinoma resistant to chemotherapy and immunotherapy. Objective: To explore the potential of radiotherapy to induce an abscopal effect and provide palliative benefits in a patient with advanced, treatment-resistant metastatic duodenal adenocarcinoma. Results: A 60-year-old female with metastatic duodenal adenocarcinoma, resistant to chemotherapy and immunotherapy, underwent palliative radiotherapy targeting eight metastatic sites. The patient received 40Gy in 20 fractions, completing 19 due to poor physical condition. Notably, radiotherapy resulted in significant regression of a metastatic lesion in the right maxillofacial region, which was not irradiated, demonstrating an abscopal effect. Tumor markers decreased, and the patient experienced substantial pain relief. Immune analysis revealed a decrease in granulocyte and lymphocyte counts and elevated IL-6 levels, which persisted throughout the treatment. Despite this positive response, the patient passed away after 23 months due to disease progression. Conclusion: This is the first reported case of an abscopal effect in metastatic duodenal adenocarcinoma, where radiotherapy not only controlled the primary lesion but also induced regression of distant metastatic lesions. These findings suggest that, for patients with multiple metastases, localized radiotherapy could be a feasible palliative option for pain relief and may provide short-term benefit. Larger studies are warranted to confirm this conclusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.